Suppr超能文献

SMOOT 文库和噬菌体诱导的 Cas9 定向进化以工程化降低脱靶活性。

SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.

机构信息

Editas Medicine, Cambridge, Massachusetts, United States of America.

出版信息

PLoS One. 2020 Apr 16;15(4):e0231716. doi: 10.1371/journal.pone.0231716. eCollection 2020.

Abstract

RNA-guided endonucleases such as Cas9 provide efficient on-target genome editing in cells but may also cleave at off-target loci throughout the genome. Engineered variants of Streptococcus pyogenes Cas9 (SpCas9) have been developed to globally reduce off-target activity, but individual off-targets may remain, or on-target activity may be compromised. In order to evolve against activity at specific off-targets while maintaining strong on-target editing, we developed a novel M13 bacteriophage-mediated selection method. Using this method, sequential rounds of positive and negative selection are used to identify mutations to Cas9 that enhance or diminish editing activity at particular genomic sequences. We also introduce scanning mutagenesis of oligo-directed targets (SMOOT), a comprehensive mutagenesis method to create highly diverse libraries of Cas9 variants that can be challenged with phage-based selection. Our platform identifies novel SpCas9 mutants which mitigate cleavage against off-targets both in biochemical assays and in T-cells while maintaining higher on-target activity than previously described variants. We describe an evolved variant, S. pyogenes Adapted to Reduce Target Ambiguity Cas9 (SpartaCas), composed of the most enriched mutations, each of unknown function. This evolved Cas9 mutant reduces off-target cleavage while preserving efficient editing at multiple therapeutically relevant targets. Directed evolution of Cas9 using our system demonstrates an improved structure-independent methodology to effectively engineer nuclease activity.

摘要

RNA 引导的内切酶,如 Cas9,可以在细胞中有效地进行靶向基因组编辑,但也可能在整个基因组的非靶向位置切割。已经开发出工程化的酿脓链球菌 Cas9(SpCas9)变体,以全局降低非靶向活性,但个别非靶向仍可能存在,或靶向活性可能受到影响。为了在特定的非靶向位置进化,同时保持强的靶向编辑,我们开发了一种新的 M13 噬菌体介导的选择方法。使用这种方法,通过正向和负向选择的连续循环,来鉴定 Cas9 的突变,这些突变可以增强或降低特定基因组序列的编辑活性。我们还引入了寡核苷酸导向目标的扫描诱变(SMOOT),这是一种全面的诱变方法,可以创建高度多样化的 Cas9 变体文库,然后可以用噬菌体选择来挑战这些文库。我们的平台鉴定了新型 SpCas9 突变体,这些突变体在生化测定和 T 细胞中都能减轻对非靶向的切割,同时保持比以前描述的变体更高的靶向活性。我们描述了一种进化的变体,S. pyogenes Adapted to Reduce Target Ambiguity Cas9(SpartaCas),由最丰富的突变组成,每个突变的功能都是未知的。这种进化的 Cas9 突变体减少了非靶向切割,同时保持了对多个治疗相关靶标的高效编辑。使用我们的系统对 Cas9 进行定向进化,展示了一种改进的、不依赖结构的方法,可有效地工程化核酸酶活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb4a/7161989/ef938a4dab3c/pone.0231716.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验